A. Prahallad

Molecular Biology · 2012–2014

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom A. Prahallad trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Kaelin

Who trusts A. Prahallad overall

  1. Kyuho Han

Papers from A. Prahallad's perspective

Ordered by how strongly the researchers A. Prahallad trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. (Journal of Clinical Oncology)
  2. The Protein Kinase Complement of the Human Genome (Science)
  3. The Concept of Synthetic Lethality in the Context of Anticancer Therapy (Nature Reviews. Cancer)
  4. The Raf/MEK/ERK pathway: new concepts of activation (Biology of the Cell)
  5. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation (Cancer Cell)
  6. A large-scale RNAi screen in human cells identifies new components of the p53 pathway (Nature)
  7. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  8. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice (Nature Genetics)
  9. A MicroRNA Signature of Hypoxia (Molecular and Cellular Biology)
  10. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. (Cell)

Their papers